COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

bioRxiv posts many COVID19-related papers. A reminder: they have not been formally peer-reviewed and should not guide health-related behavior or be reported in the press as conclusive.

30,170 Articles (22,186 medRxiv, 7,984 bioRxiv)

Most recent first Previous |  Page 2996: Articles 29951-29960  | Next

The efficacy of convalescent plasma for the treatment of severe influenza
Xu, Z., Zhou, J., Huang, Y., Liu, X., Xu, Y., Chen, S., Liu, D., Lin, Z., Liu, X., Li, Y.
10.1101/2020.02.20.20025593 — Posted: 2020-02-23
Clinical characteristics of 51 patients discharged from hospital with COVID-19 in Chongqing，China
lei, l., Jian-ya, G.
10.1101/2020.02.20.20025536 — Posted: 2020-02-23
Development and Evaluation of A CRISPR-based Diagnostic For 2019-novel Coronavirus
Hou, T., Zeng, W., Yang, M., Chen, W., Ren, L., Ai, J., Wu, J., Liao, Y., Gou, X., Li, Y., Wang, X., Su, H., Wang, J., Gu, B., Xu, T.
10.1101/2020.02.22.20025460 — Posted: 2020-02-23 Discussion: Offsite
Estimating the Asymptomatic Ratio of 2019 Novel Coronavirus onboard the Princess Cruises Ship, 2020
Mizumoto, K., Kagaya, K., Zarebski, A., Chowell, G.
10.1101/2020.02.20.20025866 — Posted: 2020-02-23
Estimating the risk of 2019 Novel Coronavirus death during the course of the outbreak in China, 2020
Mizumoto, K., Chowell, G.
10.1101/2020.02.19.20025163 — Posted: 2020-02-23 Discussion: Onsite
ACP risk grade: a simple mortality index for patients with confirmed or suspected severe acute respiratory syndrome coronavirus 2 disease (COVID-19) during the early stage of outbreak in Wuhan, China
Lu, J., Hu, S., Fan, R., Liu, Z., Yin, X., Wang, Q., Lv, Q., Cai, Z., Li, H., Hu, Y., Han, Y., Hu, H., Gao, W., Feng, S., Liu, Q., Li, H., Sun, J., Peng, J., Yi, X., Zhou, Z., Guo, Y., Hou, J.
10.1101/2020.02.20.20025510 — Posted: 2020-02-23
Association of radiologic findings with mortality of patients infected with 2019 novel coronavirus in Wuhan, China
Yuan, M., Yin, W., Tao, Z., Tan, W., Hu, Y.
10.1101/2020.02.22.20024927 — Posted: 2020-02-23
Effectiveness of intervention strategies for Coronavirus Disease 2019 and an estimation of its peak time
pan, j., yao, y., liu, z., li, m., wang, y., dong, w., kan, h., wang, w.
10.1101/2020.02.19.20025387 — Posted: 2020-02-23
A descriptive study of the impact of diseases control and prevention on the epidemics dynamics and clinical features of SARS-CoV-2 outbreak in Shanghai, lessons learned for metropolis epidemics prevention
Lu, H., Ai, J., Shen, Y., Li, Y., Li, T., Zhou, X., Zhang, H., Zhang, Q., Ling, Y., Wang, S., Qu, H., Gao, Y., Li, Y., Yu, K., Zhu, D., Zhu, H., Tian, R., Zeng, M., Li, Q., Song, Y., Li, X., Xu, J., Xu, J., Mao, E., Hu, B., Li, X., Zhu, L., Zhang, W.
10.1101/2020.02.19.20025031 — Posted: 2020-02-23
Evolving epidemiology of novel coronavirus diseases 2019 and possible interruption of local transmission outside Hubei Province in China: a descriptive and modeling study
Zhang, J., Litvinova, M., Wang, W., Wang, Y., Deng, X., Chen, X., Li, M., Zheng, W., Yi, L., Chen, X., Wu, Q., Liang, Y., Wang, X., Yang, J., Sun, K., Longini, I. M., Halloran, M. E., Wu, P., Cowling, B. J., Merler, S., Viboud, C., Vespignani, A., Ajelli, M., Yu, H.
10.1101/2020.02.21.20026328 — Posted: 2020-02-23

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).